Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenic Cell Death as a Novel Mechanism of Mitomycin C Activity in Bladder Cancer

NCT04256616 is registered in ClinicalTrials.gov with Istituto Clinico Humanitas as lead sponsor.

NCT NCT04256616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04256616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenic Cell Death as a Novel Mechanism of Mitomycin C Activity in Bladder Cancer
Lead sponsor
Istituto Clinico Humanitas
Phase
Observational
Overall status
Unknown status
Start date
June 27, 2018
Completion date
September 30, 2020
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer